Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984761 · ClinicalTrials.gov registry record · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
A NA study of Lung Neoplasm, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 670
- Enrollment target
- 17
- Study locations
NCT02984761: Recruiting NA study of Lung Neoplasm, sponsored by VA Office of Research and Development.
NCT02984761 is a NA study of Lung Neoplasm that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 670 participants, above the 472-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (42% higher). The trial reports 17 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984761, a NA study of Lung Neoplasm, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 670 participants
- Enrollment target
- 17
- Study locations
Study Summary
Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments and are therefore conducting this study to determine if one may be possibly better than the other.
Primary Outcome
Survival estimates will include death from any cause.
Conditions Studied
Interventions
- RADIATION Stereotactic Radiotherapy
- PROCEDURE Anatomic Pulmonary Resection
Study Locations (17)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Florida
- Bay Pines VA Healthcare System, Pay Pines, FL - Bay Pines
- Miami VA Healthcare System, Miami, FL - Miami
Pennsylvania
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Maryland
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 670 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2034-03-31 |
| Phase | NA |
What NCT02984761 shows while recruiting
NCT02984761 is an interventional study that assigns participants to a tested intervention. The registered 670 participants enrollment target is mid-sized for trials with a published cap, above the 472-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (42% higher).
The record links to 1 condition, with Lung Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Stereotactic Radiotherapy is the first listed.
NCT02984761 lists 17 locations in 14 states (California, Florida, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT02984761 about?
NCT02984761 is a clinical study titled "Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy". Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments an...
What is the current status of trial NCT02984761?
This trial is currently recruiting. It is a NA study. The enrollment target is 670 participants. The study started on 2017-04-13. Estimated completion is 2034-03-31.
What conditions does trial NCT02984761 study?
This clinical trial studies the following conditions: Lung Neoplasm.
What interventions are being tested in trial NCT02984761?
The interventions under investigation include: Stereotactic Radiotherapy (RADIATION), Anatomic Pulmonary Resection (PROCEDURE).
Who is sponsoring clinical trial NCT02984761?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02984761 being conducted?
This trial has 17 study locations across California, Florida, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02984761's enrollment target sits among peer trials
670 2nd of 8 the highest of 8 other Lung Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules
ACTIVE NOT RECRUITING · NA
-
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
ACTIVE NOT RECRUITING · NA
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
-
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
RECRUITING
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05727904 · 670 participants · Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- NCT06223867 · 670 participants · NA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI